Hemispheric Hypoperfusion in Immune Effector Cell-Associated Neurotoxicity Syndrome following Chimeric Antigen Receptor T-Cell Therapy.

Lambert, Nicolas; Ly, Julien; Deprez, Louis; WILLEMS, Evelyne

doi:10.1002/ana.26832

Article (Scientific journals)

Hemispheric Hypoperfusion in Immune Effector Cell-Associated Neurotoxicity Syndrome following Chimeric Antigen Receptor T-Cell Therapy.

Lambert, Nicolas; Ly, Julien; Deprez, Louis et al.

2023 • In Annals of Neurology

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/309283

DOI
10.1002/ana.26832

PubMed
37975425

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

document.pdf

Publisher postprint (3.22 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Hematology
Neurology

Author, co-author :

Lambert, Nicolas ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurologie

Ly, Julien ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurologie

Deprez, Louis ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiodiagnostic

WILLEMS, Evelyne ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique

Language :

English

Title :

Hemispheric Hypoperfusion in Immune Effector Cell-Associated Neurotoxicity Syndrome following Chimeric Antigen Receptor T-Cell Therapy.

Publication date :

17 November 2023

Journal title :

Annals of Neurology

ISSN :

0364-5134

eISSN :

1531-8249

Publisher :

Wiley, United States

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26832

Available on ORBi :

since 29 November 2023

Statistics

Number of views

23 (4 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Neelapu SS, Tummala S, Kebriaei P, et al. Chimeric antigen receptor T-cell therapy–assessment and management of toxicities. Nat Rev Clin Oncol 2018;15:47–62. https://doi.org/10.1038/nrclinonc.2017.148.
Apfaltrer P, Wenz H, Böhme J, et al. FLAIR vascular hyperintensities indicate slow poststenotic blood flow in ICA stenosis. Clin Neuroradiol 2021;31:827–831. https://doi.org/10.1007/s00062-020-00941-y.
Cappell KM, Kochenderfer JN. Long-term outcomes following CAR T cell therapy: what we know so far. Nat Rev Clin Oncol 2023;20:359–371. https://doi.org/10.1038/s41571-023-00754-1.
Genoud V, Migliorini D. Novel pathophysiological insights into CAR-T cell associated neurotoxicity. Front Neurol 2023;14:1108297. https://doi.org/10.3389/fneur.2023.1108297.